Showing results (31-40 of 75) with videos related to
Sort By:
Pageof 8
Cell Cycle (Georgetown, Tex.)|November 23, 2007
Suppression of TGF-beta signaling by phospholipase DNoga Gadir, Evan Lee, Avalon Garcia, et al.Biochemical and Biophysical Research Communications|November 1, 2002
Elevated phospholipase D activity induces apoptosis in normal rat fibroblastsMinghao Zhong, Troy Joseph, Desmond Jackson, et al.Cancer Letters|September 26, 2021
Cancer cells with defective RB and CDKN2A are resistant to the apoptotic effects of rapamycinSohag Chakraborty, Matthew B Utter, Maria A Frias, et al.Molecular and Cellular Biology|August 19, 2005
Survival signals generated by estrogen and phospholipase D in MCF-7 breast cancer cells are dependent on MycVanessa Rodrik, Yang Zheng, Faith Harrow, et al.The Journal of Biological Chemistry|October 24, 2008
Differential dependence of hypoxia-inducible factors 1 alpha and 2 alpha on mTORC1 and mTORC2Alfredo Toschi, Evan Lee, Noga Gadir, et al.FEBS Letters|September 26, 2006
Myc stabilization in response to estrogen and phospholipase D in MCF-7 breast cancer cellsVanessa Rodrik, Evan Gomes, Li Hui, et al.Cancer Letters|October 24, 2007
Phospholipase D provides a survival signal in human cancer cells with activated H-Ras or K-RasMing Shi, Yang Zheng, Avalon Garcia, et al.Cancer Letters|February 10, 2015
Rapamycin-induced G1 cell cycle arrest employs both TGF-β and Rb pathwaysAmrita Chatterjee, Suman Mukhopadhyay, Kaity Tung, et al.International Journal of Medical Informatics|June 21, 2008
Association of a clinical knowledge support system with improved patient safety, reduced complications and shorter length of stay among Medicare beneficiaries in acute care hospitals in the United StatesPeter A Bonis, Gary T Pickens, David M Rind, et al.Molecular Cancer Therapeutics|February 27, 2016
The Enigma of Rapamycin DosageSuman Mukhopadhyay, Maria A Frias, Amrita Chatterjee, et al.Pageof 8